Literature DB >> 22961231

Could co-payments on drugs help to make EU health care systems less open to political influence?

Livio Garattini, Katelijne van de Vooren.   

Abstract

Mesh：

Year:  2013        PMID： 22961231     DOI： 10.1007/s10198-012-0428-1

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  13 in total

1.  HPV vaccination for boys? Talking economic sense.

Authors:  Livio Garattini; Katelijne van de Vooren
Journal:  J Sex Med       Date:  2012-07-03       Impact factor: 3.802

2.  Off-patent drugs in Italy. A short-sighted view?

Authors:  Livio Garattini; Simone Ghislandi
Journal:  Eur J Health Econ       Date:  2006-03

3.  Lessons from international experience in controlling pharmaceutical expenditure. I: Influencing patients.

Authors:  N Freemantle; K Bloor
Journal:  BMJ       Date:  1996-06-08

4.  France: Health system review.

Authors:  Karine Chevreul; Isabelle Durand-Zaleski; Stéphane Bahrami Bahrami; Cristina Hernández-Quevedo; Philipa Mladovsky
Journal:  Health Syst Transit       Date:  2010

5.  The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany.

Authors:  Tom Stargardt
Journal:  Eur J Health Econ       Date:  2009-07-29

6.  Ethics for end-of-life treatments: metastatic colorectal cancer is one example.

Authors:  Livio Garattini; Katelijne van de Vooren; Alberto Zaniboni
Journal:  Health Policy       Date:  2012-09-14       Impact factor: 2.980

7.  Increased ambulatory care copayments and hospitalizations among the elderly.

Authors:  Amal N Trivedi; Husein Moloo; Vincent Mor
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

8.  Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.

Authors:  Michael Drummond; Bengt Jönsson; Frans Rutten; Tom Stargardt
Journal:  Eur J Health Econ       Date:  2010-08-28

9.  Patient organizations' funding from pharmaceutical companies: is disclosure clear, complete and accessible to the public? An Italian survey.

Authors:  Cinzia Colombo; Paola Mosconi; Walter Villani; Silvio Garattini
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

10.  What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.

Authors:  Marin C Gemmill; Sarah Thomson; Elias Mossialos
Journal:  Int J Equity Health       Date:  2008-05-02
View more
  3 in total

1.  Is the US "leading from behind" on health policy?

Authors:  Peter J Neumann; Cayla J Saret
Journal:  Eur J Health Econ       Date:  2013-12-10

2.  European Medicines Agency: leave the UK but remain the same.

Authors:  Livio Garattini; Alessandro Curto
Journal:  J R Soc Med       Date:  2016-09       Impact factor: 5.344

3.  Competition in health markets: is something rotten?

Authors:  Livio Garattini; Anna Padula
Journal:  J R Soc Med       Date:  2018-12-03       Impact factor: 5.344
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.